Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,623 | 15,841 | 6,252 | 18,221 | 1,273 |
| Receivables | 13,211 | 10,113 | 5,925 | 2,720 | 3,785 |
| Inventories | 8,633 | 6,618 | 8,149 | 8,224 | 9,827 |
| Other current assets | 0 | 0 | 0 | 0 | 3,063 |
| TOTAL | $42,678 | $34,260 | $21,716 | $30,136 | $19,118 |
| Non-Current Assets | |||||
| PPE Net | 12,676 | 12,565 | 13,260 | 14,512 | 16,016 |
| Intangibles | 25,751 | 28,123 | 30,606 | 0 | 0 |
| Other Non-Current Assets | 5,951 | 6,249 | 7,135 | 1,919 | 1,779 |
| TOTAL | $44,378 | $46,937 | $51,001 | $16,431 | $17,795 |
| Total Assets | $87,056 | $81,197 | $72,717 | $46,567 | $36,913 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 25,909 | 9,301 | 3,899 | 2,318 | 1,524 |
| Accounts payable and accrued liabilities | 2,687 | 1,895 | 3,379 | 1,692 | 3,800 |
| Accrued Expenses | 14,851 | 11,650 | 12,467 | 6,871 | 9,811 |
| Other current liabilities | N/A | N/A | N/A | N/A | 674 |
| TOTAL | $45,188 | $24,228 | $21,085 | $11,319 | $22,002 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,691 | 18,779 | 19,147 | 19,119 | 62,229 |
| Deferred Revenues | 360 | 374 | 427 | 438 | 6,193 |
| Other Non-Current Liabilities | 3,359 | 5,152 | 6,941 | 794 | 1,287 |
| TOTAL | $12,215 | $25,559 | $28,074 | $22,312 | $65,562 |
| Total Liabilities | $57,403 | $49,787 | $49,159 | $33,631 | $87,564 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 182,275 | 173,483 | 145,531 | 110,691 | 102,093 |
| Common Shares | 1 | 1 | 1 | 1 | N/A |
| Retained earnings | -357,371 | -340,817 | -320,649 | -283,474 | -265,572 |
| TOTAL | $29,653 | $31,410 | $23,558 | $12,936 | $-50,651 |
| Total Liabilities And Equity | $87,056 | $81,197 | $72,717 | $46,567 | $36,913 |